No abstract available
MeSH terms
-
Adult
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Diagnosis, Differential
-
Erythema Nodosum / diagnosis
-
Female
-
Glutamic Acid
-
Humans
-
Indoles / administration & dosage
-
Indoles / adverse effects*
-
Male
-
Melanoma / drug therapy*
-
Melanoma / genetics
-
Middle Aged
-
Molecular Targeted Therapy
-
Panniculitis / chemically induced*
-
Panniculitis / diagnosis*
-
Point Mutation*
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
-
Proto-Oncogene Proteins B-raf / genetics
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / genetics
-
Sulfonamides / administration & dosage
-
Sulfonamides / adverse effects*
-
Valine
-
Vemurafenib
Substances
-
Antineoplastic Agents
-
Indoles
-
Sulfonamides
-
Vemurafenib
-
Glutamic Acid
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf
-
Valine